MARKET

CLNN

CLNN

Clene
NASDAQ
2.720
+0.090
+3.42%
After Hours: 2.650 -0.07 -2.57% 16:41 05/12 EDT
OPEN
2.760
PREV CLOSE
2.630
HIGH
2.799
LOW
2.600
VOLUME
55.40K
TURNOVER
--
52 WEEK HIGH
9.20
52 WEEK LOW
2.550
MARKET CAP
24.43M
P/E (TTM)
-0.6852
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CLNN last week (0505-0509)?
Weekly Report · 10h ago
Clene Inc. Reports Reduced Losses Amid Strategic Cost-Saving Measures
TipRanks · 3d ago
Clene’s Strategic Financial Management and Promising Clinical Developments Drive Buy Rating
TipRanks · 4d ago
JonesTrading Sticks to Their Buy Rating for Clene (CLNN)
TipRanks · 4d ago
CLENE INC. <CLNN.O>: BENCHMARK CUTS TARGET PRICE TO $33 FROM $84
Reuters · 4d ago
Clene Is Maintained at Buy by D. Boral Capital
Dow Jones · 4d ago
D. Boral Capital Maintains Buy on Clene, Maintains $23 Price Target
Benzinga · 4d ago
Clene’s Strategic Focus and Promising CNM-Au8 Developments Drive Buy Rating
TipRanks · 5d ago
More
About CLNN
Clene Inc. is a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis, Parkinson's disease, and multiple sclerosis. It specializes in the discovery, development, and commercialization of clean-surfaced nanotechnology (CSN) therapeutics. CNM-Au8, the lead asset, is a concentrated aqueous suspension of catalytically active, clean-surfaced, faceted gold nanocrystals. CNM-Au8’s mechanism of action targets mitochondrial dysfunction by catalyzing the production of nicotinamide adenine dinucleotide. Its CNM-ZnAg is a broad-spectrum antiviral, antibacterial agent comprised of zinc (Zn2+) and silver (Ag+) ions under development to treat infectious disease and to provide immune support for symptom resolution. Its CNM-AgZn17 is a gel polymer suspension of Zn2+ and Ag+ under development for the treatment of infectious diseases and to support wound healing.

Webull offers Clene Inc. stock information, including NASDAQ: CLNN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CLNN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CLNN stock methods without spending real money on the virtual paper trading platform.